The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)
Open accessAbstract
AIMS: Hypertrophic cardiomyopathy (HCM) is a leading cause of sudden cardiac death (SCD) in young adults. Current risk algorithms provide only a crude estimate of risk and fail to account for the different effect size of individual risk factors. The aim of this study was to develop and validate a new SCD risk prediction model that provides individualized risk estimates. METHODS AND RESULTS: The prognostic model was derived from a retrospective, multi-centre longitudinal cohort study. The model was developed from the entire data set using the Cox proportional hazards model and internally validated using bootstrapping. The cohort consisted of 3675 consecutive patients from six centres. During a follow-up period of 24 313 patient-years (median 5.7 years), 198 patients (5%) died suddenly or had an appropriate implantable cardioverter defibrillator (ICD) shock. Of eight pre-specified predictors, age, maximal left ventricular wall thickness, left atrial diameter, left ventricular outflow tract gradient, family history of SCD, non-sustained ventricular tachycardia, and unexplained syncope were associated with SCD/appropriate ICD shock at the 15% significance level. These predictors were included in the final model to estimate individual probabilities of SCD at 5 years. The calibration slope was 0.91 (95% CI: 0.74, 1.08), C-index was 0.70 (95% CI: 0.68, 0.72), and D-statistic was 1.07 (95% CI: 0.81, 1.32). For every 16 ICDs implanted in patients with ≥4% 5-year SCD risk, potentially 1 patient will be saved from SCD at 5 years. A second model with the data set split into independent development and validation cohorts had very similar estimates of coefficients and performance when externally validated. CONCLUSION: This is the first validated SCD risk prediction model for patients with HCM and provides accurate individualized estimates for the probability of SCD using readily collected clinical parameters.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In general, a history of syncope in patients with structural heart disease or inheritable arrhythmia syndromes is associated with a two- to four-fold increased risk of death, 348,350-353 but varies between specific conditions. 354-356”
From 2018 ESC Guidelines for the diagnosis and management of syncope (2018) · cites this paper as [350]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the largest multicentre study to date (>3600 patients with HCM), syncope was an independent predictor of the composite of SCD and ICD discharge (hazard ratio 2.05, 95% CI 1.48-2.82). 350”
From 2018 ESC Guidelines for the diagnosis and management of syncope (2018) · cites this paper as [350]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“LVOT obstruction has been identified as a predictor of sudden death in some but not all studies”
From Current management of hypertrophic cardiomyopathy (2025) · cites this paper as [98]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“initially validated in 2013.”
From Current management of hypertrophic cardiomyopathy (2025) · cites this paper as [98]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multiple Imputation for Nonresponse in Surveys
Rubin, D. B. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316696 · Cited by 20,701
Multiple imputation using chained equations: Issues and guidance for practice
White, I. R., Royston, P., & Wood, A. M. (2011) · Statistics in Medicine · doi:10.1002/sim.4067 · Cited by 9,792
Regression Modeling Strategies
Harrell, F. E. (2001) · Springer series in statistics · doi:10.1007/978-1-4757-3462-1 · Cited by 9,270
Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating
Steyerberg, E. W. (2019) · Statistics for Biology and Health · doi:10.1007/978-3-030-16399-0 · Cited by 3,281
Partial residuals for the proportional hazards regression model
SCHOENFELD, D. (1982) · Biometrika · doi:10.1093/biomet/69.1.239 · Cited by 3,111
Elliot, P. M., Andersson, B., Arbustini, E., Bilińska, Z. T., Cecchi, F., Charron, P., Dubourg, O., Kühl, U., Maisch, B., McKenna, W. J., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm342 · Cited by 2,995
Self-citationPeduzzi, P., Concato, J., Feinstein, A. R., & Holford, T. R. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(95)00048-8 · Cited by 2,154
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318223e2bd · Cited by 2,116
Prognosis and prognostic research: what, why, and how?
Moons, K. G. M., Royston, P., Vergouwe, Y., Grobbee, D. E., & Altman, D. G. (2009) · BMJ · doi:10.1136/bmj.b375 · Cited by 1,337
Maron, M. S., Olivotto, I., Betocchi, S., Casey, S. A., Lesser, J. R., Losi, M. A., Cecchi, F., & Maron, B. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021332 · Cited by 1,259
Research works printed but not linked: 1
- 2012, Circulation: Arrhythmia and Electrophysiology, 6, 443
Cited by
Sorted by citations
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2021) · PubMed · doi:10.1093/eurheartj/ehab670 · Cited by 20,604
2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Authors/Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A. A., Lafont, A., Limongelli, G., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu284 · Cited by 4,332
Self-citationPriori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., Elliott, P. M., Fitzsimons, D., Hatala, R., Hindricks, G., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv316 · Cited by 3,893
Deo, R. C. (2015) · Circulation · doi:10.1161/circulationaha.115.001593 · Cited by 3,466
Zeppenfeld, K., Tfelt‐Hansen, J., Riva, M., Winkel, B. G., Behr, E. R., Blom, N. A., Charron, P., Corrado, D., Dagres, N., de Chillou, C., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac262 · Cited by 3,432
2023 ESC guidelines for the management of cardiomyopathies
Arbelo, E., Protonotarios, A., Gimeno, J. R., Arbustini, E., Barriales-Villa, R., Basso, C., Bezzina, C. R., Biagini, E., Blom, N. A., de Boer, R. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad194 · Cited by 2,844
Self-citation2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Authors/Task Force Members:, McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2333 · Cited by 2,356
2018 ESC Guidelines for the diagnosis and management of syncope
Brignole, M., Moya, A., de Lange, F. J., Deharo, J.-C., Elliott, P. M., Fanciulli, A., Fedorowski, A., Furlan, R., Kenny, R. A., Martín, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy037 · Cited by 1,951
2020 ESC guidelines on sports cardiology and exercise in patients with cardiovascular disease
Pelliccia, A., Sharma, S., Gati, S., Bäck, M., Börjesson, M., Caselli, S., Collet, J.-P., Corrado, D., Drezner, J. A., Halle, M., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa605 · Cited by 1,958
Al‐Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T. M., Field, M. E., Fonarow, G. C., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.054 · Cited by 1,902
Authors Task Force Members, Priori, S. G., Blomström‐Lundqvist, C., Mazzanti, A., Blom, N. A., Borggrefe, M., Camm, J. A., Elliot, P. M., Fitzsimons, D., Hatala, R., et al. (2015) · EP Europace · doi:10.1093/europace/euv319 · Cited by 1,671
Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy
Marian, A. J., & Braunwald, E. (2017) · Circulation Research · doi:10.1161/circresaha.117.311059 · Cited by 1,403
Chan, R. H., Maron, B. J., Olivotto, I., Pencina, M. J., Assenza, G. E., Haas, T., Lesser, J. R., Gruner, C., Crean, A. M., Rakowski, H., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.007094 · Cited by 962
Self-citationOmmen, S. R., Mital, S. R., Burke, M. A., Day, S. M., Deswal, A. M., Elliot, P. M., Evanovich, L. L., Hung, J., Joglar, J. A., Kantor, P. F., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.044 · Cited by 997
Ho, C. Y., Day, S. M., Ashley, E. A., Michels, M., Pereira, A. C., Jacoby, D., Cirino, A. L., Fox, J. C., Lakdawala, N. K., Ware, J. S., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.033200 · Cited by 860
Self-citationOmmen, S. R., Ho, C. Y., Asif, I. M., Balaji, S., Burke, M. A., Day, S. M., Dearani, J. A., Epps, K. C., Evanovich, L., Ferrari, V. A., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001250 · Cited by 807
Al‐Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T. M., Field, M. E., Fonarow, G. C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000549 · Cited by 777
Al‐Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T. M., Field, M. E., Fonarow, G. C., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.10.035 · Cited by 743
The Spectrum of Epidemiology Underlying Sudden Cardiac Death
Hayashi, M., Shimizu, W., & Albert, C. M. (2015) · Circulation Research · doi:10.1161/circresaha.116.304521 · Cited by 741
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy
Ommen, S. R., Mital, S., Burke, M. A., Day, S. M., Deswal, A., Elliott, P., Evanovich, L. L., Hung, J., Joglar, J. A., Kantor, P., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.045 · Cited by 643
Ezekowitz, J. A., O'Meara, E., McDonald, M. A., Abrams, H., Chan, M., Ducharme, A., Giannetti, N., Grzeslo, A., Hamilton, P. G., Heckman, G. A., et al. (2017) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.08.022 · Cited by 676
Al‐Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T. M., Field, M. E., Fonarow, G. C., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.053 · Cited by 689
How to develop a more accurate risk prediction model when there are few events
Pavlou, M., Ambler, G., Seaman, S. R., Guttmann, O. P., Elliot, P. M., King, M., & Omar, R. (2015) · BMJ · doi:10.1136/bmj.h3868 · Cited by 698
Self-citationMaron, B. J., Ommen, S. R., Semsarian, C., Spirito, P., Olivotto, I., & Maron, M. S. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.05.003 · Cited by 652
Al‐Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T. M., Field, M. E., Fonarow, G. C., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.10.036 · Cited by 644
Artificial Intelligence Transforms the Future of Health Care
Noorbakhsh-Sabet, N., Zand, R., Zhang, Y., & Abedi, V. (2019) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.01.017 · Cited by 626
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy
Ommen, S. R., Mital, S. R., Burke, M. A., Day, S. M., Deswal, A. M., Elliot, P. M., Evanovich, L. L., Hung, J., Joglar, J. A., Kantor, P. F., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000937 · Cited by 654
2018 ESC Guidelines for the diagnosis and management of syncope
Brignole, M., Moya‐Mitjans, À., de Lange, F. J., Deharo, J., Elliot, P. M., Fanciulli, A., Fedorowski, A., Furlan, R., Kenny, R. A., Martiın, A., et al. (2018) · Kardiologia Polska · doi:10.5603/kp.2018.0161 · Cited by 475
Pavlou, M., Ambler, G., Seaman, S. R., Iorio, M. D., & Omar, R. (2015) · Statistics in Medicine · doi:10.1002/sim.6782 · Cited by 441
Self-citationAl-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000548 · Cited by 412
2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy
Ommen, S. R., Ho, C. Y., Asif, I. M., Balaji, S., Burke, M. A., Day, S. M., Dearani, J. A., Epps, K., Evanovich, L., Ferrari, V. A., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.02.014 · Cited by 425
Maron, B. J., Rowin, E. J., Casey, S. A., Link, M. S., Lesser, J. R., Chan, R. H. M., Garberich, R. F., Udelson, J. E., & Maron, M. S. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.02.061 · Cited by 317
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Elliot, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagège, A. A., Lafont, A. M., Limongelli, G., Mahrholdt, H., et al. (2014) · Kardiologia Polska · doi:10.5603/kp.2014.0212 · Cited by 342
Self-citationWriting Committee Members, Ommen, S. R., Mital, S., Burke, M. A., Day, S. M., Deswal, A., Elliott, P., Evanovich, L. L., Hung, J., Joglar, J. A., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000938 · Cited by 336
Distinct Subgroups in Hypertrophic Cardiomyopathy in the NHLBI HCM Registry
Neubauer, S., Kolm, P., Ho, C. Y., Kwong, R. Y. K., Desai, M. Y., Dolman, S. F., Appelbaum, E. A., Desvigne-Nickens, P. M., Dimarco, J., Friedrich, M. G., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.08.1057 · Cited by 329
Self-citationMaron, M. S., Rowin, E. J., Wessler, B. S., Mooney, P., Fatima, A., Patel, P. P., Koethe, B. C., Romashko, M. D., Link, M. S., & Maron, B. J. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.1391 · Cited by 323
Siontis, K. C., Geske, J. B., Ong, K., Nishimura, R. A., Ommen, S. R., & Gersh, B. J. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001002 · Cited by 276
Geske, J. B., Ommen, S. R., & Gersh, B. J. (2018) · JACC Heart Failure · doi:10.1016/j.jchf.2018.02.010 · Cited by 319
Marijon, É., Narayanan, K., Smith, K. L., Barra, S., Basso, C., Blom, M. T., Crotti, L., d’Ávila, A., Deo, R., Dumas, F., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00875-9 · Cited by 346
Steinberg, J. S., Varma, N., Cygankiewicz, I., Aziz, P., Balsam, P., Baranchuk, A., Cantillon, D. J., Dilaveris, P., Dubner, S. J., El-Sherif, N., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.03.038 · Cited by 303
Cardim, N. M., Galderisi, M., Edvardsen, T., Plein, S., Popescu, B. A., D’Andrea, A., Bruder, O., Cosyns, B., Davin, L., Donal, E., et al. (2015) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeu291 · Cited by 283
Hypertrophic obstructive cardiomyopathy
Veselka, J., Anavekar, N. S., & Charron, P. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31321-6 · Cited by 257
Cadrin‐Tourigny, J., Bosman, L. P., Nozza, A., Wang, W., Tadros, R., Bhonsale, A., Bourfiss, M., Fortier, A., Lie, Ø. H., Saguner, A. M., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz103 · Cited by 264
Using machine learning for healthcare challenges and opportunities
Alanazi, A. (2022) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2022.100924 · Cited by 287
Mont, L., Pelliccia, A., Sharma, S., Biffi, A., Börjesson, M., Brugada, J., Carré, F., Guasch, E., Heidbüchel, H., Gerche, A. L., et al. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316676042 · Cited by 268
Self-citationMaron, B. J., Rowin, E. J., Casey, S. A., & Maron, M. S. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2015.0354 · Cited by 246
Norrish, G., Ding, T., Field, E., Ziółkowska, L., Olivotto, I., Limongelli, G., Anastasakis, A., Weintraub, R. G., Biagini, E., Ragni, L., et al. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.2861 · Cited by 255
Self-citationMolecular Genetic Basis of Hypertrophic Cardiomyopathy
Marian, A. J. (2021) · Circulation Research · doi:10.1161/circresaha.121.318346 · Cited by 250
Mentias, A. G., Raeisi‐Giglou, P., Smedira, N. G., Feng, K., Sato, K., Wazni, O. M., Kanj, M., Flamm, S. D., Thamilarasan, M., Popović, Z., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.05.060 · Cited by 240
An Expert Consensus Document on the Management of Cardiovascular Manifestations of Fabry Disease
Linhart, A., Germain, D. P., Olivotto, I., Akhtar, M. M., Anastasakis, A., Hughes, D. A., Namdar, M., Pieroni, M., Hagège, A. A., Cecchi, F., et al. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1960 · Cited by 233
Self-citationA Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy
Miron, A., Lafrenière‐Roula, M., Fan, C. S., Armstrong, K. R., Dragulescu, A., Papaz, T., Manlhiot, C., Kaufman, B. D., Butts, R. J., Gardin, L., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.047235 · Cited by 225
Mont, L., Pelliccia, A., Sharma, S., Biffi, A., Börjesson, M., Brugada, J., Carré, F., Guasch, E., Heidbüchel, H., Gerche, A. L., et al. (2016) · EP Europace · doi:10.1093/europace/euw243 · Cited by 226
Self-citationO’Mahony, C., Jichi, F., Ommen, S. R., Christiaans, I., Arbustini, E., Garcia-Pavia, P., Cecchi, F., Olivotto, I., Kitaoka, H., Gotsman, I., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.030437 · Cited by 201
Self-citationNagueh, S. F., Phelan, D. M. J., Abraham, T. P., Armour, A. C., Desai, M. Y., Dragulescu, A., Gilliland, Y. E., Lester, S. J., Maldonado, Y., MOHIDDIN, S. A., et al. (2022) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2022.03.012 · Cited by 216
JCS/JHRS 2019 Guideline on Non-Pharmacotherapy of Cardiac Arrhythmias
Nogami, A., Kurita, T., Abe, H., Andò, K., Ishikawa, T., Imai, K., Usui, A., Okishige, K., Kusano, K., Kumagai, K., et al. (2021) · Circulation Journal · doi:10.1253/circj.cj-20-0637 · Cited by 205
Hypertrophic Cardiomyopathy: The Future of Treatment
Tuohy, C. V., Kaul, S., Song, H. K., Nazer, B., & Heitner, S. B. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1715 · Cited by 195
Aminizadeh, S., Heidari, A., Toumaj, S., Darbandi, M., Navimipour, N. J., Rezaei, M., Talebi, S., Azad, P., & Ünal, M. (2023) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2023.107745 · Cited by 209
Hypertrophic Cardiomyopathy: An Overview of Genetics and Management
Teekakirikul, P., Zhu, W., Huang, H. C., & Fung, E. (2019) · Biomolecules · doi:10.3390/biom9120878 · Cited by 191
Apical Hypertrophic Cardiomyopathy: The Variant Less Known
Hughes, R. K., Knott, K. D., Malcolmson, J. W., Augusto, J. B., MOHIDDIN, S. A., Kellman, P., Moon, J., & Captur, G. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015294 · Cited by 183
Maron, B. J., Casey, S. A., Chan, R. H. M., Garberich, R., Rowin, E. J., & Maron, M. S. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.05.047 · Cited by 181
Hypertrophic Obstructive Cardiomyopathy
Nishimura, R. A., Seggewiß, H., & Schaff, H. V. (2017) · Circulation Research · doi:10.1161/circresaha.116.309348 · Cited by 182
Randomized Trial of Metoprolol in Patients With Obstructive Hypertrophic Cardiomyopathy
Dybro, A. M., Rasmussen, T. B., Nielsen, R. R., Andersen, M. J., Jensen, M. K., & Poulsen, S. H. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.07.065 · Cited by 177
Sedaghat‐Hamedani, F., Kayvanpour, E., Tugrul, O. F., Lai, A., Amr, A., Haas, J., Proctor, T., Ehlermann, P., Jensen, K., Katus, H. A., et al. (2017) · Clinical Research in Cardiology · doi:10.1007/s00392-017-1155-5 · Cited by 174
Prediction of Thrombo-Embolic Risk in Patients with Hypertrophic Cardiomyopathy (HCM Risk-CVA)
Guttmann, O. P., Pavlou, M., O’Mahony, C., Monserrat, L., Anastasakis, A., Rapezzi, C., Biagini, E., Gimeno, J. R., Limongelli, G., García‐Pavía, P., et al. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.316 · Cited by 165
Self-citationRobinson, S., Ring, L. S., Oxborough, D., Harkness, A., Bennett, S., Rana, B. S., Sutaria, N., Giudice, F. L., Shun-Shin, M. J., Paton, M. F., et al. (2024) · Echo Research and Practice · doi:10.1186/s44156-024-00051-2 · Cited by 179
JCS/JHRS 2019 guideline on non‐pharmacotherapy of cardiac arrhythmias
Nogami, A., Kurita, T., Abe, H., Andò, K., Ishikawa, T., Imai, K., Usui, A., Okishige, K., Kusano, K., Kumagai, K., et al. (2021) · Journal of Arrhythmia · doi:10.1002/joa3.12491 · Cited by 166
Verstraelen, T. E., van Lint, F. H. M., Bosman, L. P., de Brouwer, R., Proost, V. M., Abeln, B. G. S., Taha, K., Zwinderman, A. H., Dickhoff, C., Oomen, T., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab294 · Cited by 163
Self-citationCardiopulmonary Exercise Testing and Prognosis in Hypertrophic Cardiomyopathy
Coats, C. J., Rantell, K., Bartnik, A., Patel, A., Mist, B., McKenna, W. J., & Elliott, P. M. (2015) · Circulation: Heart Failure · doi:10.1161/circheartfailure.114.002248 · Cited by 148
Self-citationNonfamilial Hypertrophic Cardiomyopathy: Prevalence, Natural History, and Clinical Implications.
Ingles, J., Burns, C., Bagnall, R. D., Lam, L., Yeates, L., Sarina, T., Puranik, R., Briffa, T. G., Atherton, J. J., Driscoll, T., et al. (2017) · PubMed · doi:10.1161/circgenetics.116.001620 · Cited by 148
Pharmacological Treatment of Hypertrophic Cardiomyopathy: Current Practice and Novel Perspectives
Ammirati, E., Contri, R., Coppini, R., Cecchi, F., Frigerio, M., & Olivotto, I. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.541 · Cited by 148
Arrhythmogenic Right Ventricular Cardiomyopathy
Krahn, A. D., Wilde, A. A. M., Calkins, H. G., Gerche, A. L., Cadrin‐Tourigny, J., Roberts, J. D., & Han, H. (2022) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2021.12.002 · Cited by 158
Vriesendorp, P. A., Schinkel, A. F. L., Liebregts, M., Theuns, D. A. M. J., Cleemput, J. V., ten Cate, F. J., Willems, R., & Michels, M. (2015) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.114.002553 · Cited by 141
Survival After Alcohol Septal Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy
Batzner, A., Pfeiffer, B., Neugebauer, A., Aicha, D., Blank, C., & Seggewiss, H. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.09.064 · Cited by 132
Hypertrophic cardiomyopathy: genetics and clinical perspectives
Wolf, C. M. (2019) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2019.02.01 · Cited by 139
Cadrin‐Tourigny, J., Bosman, L. P., Nozza, A., Wang, W., Tadros, R., Bhonsale, A., Bourfiss, M., Fortier, A., Lie, Ø. H., Saguner, A. M., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac180 · Cited by 136
Axelsson, A., Iversen, K. K., Vejlstrup, N. G., Ho, C. Y., Norsk, J. B., Langhoff, L., Ahtarovski, K. A., Corell, P., Havndrup, O., Jensen, M. K., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70241-4 · Cited by 138
Spezzacatene, A., Sinagra, G., Merlo, M., Barbati, G., Graw, S. L., Brun, F., Slavov, D. B., Lenarda, A. D., Salcedo, E. E., Towbin, J. A., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002149 · Cited by 138
Xu, J., Zhuang, B., Sirajuddin, A., Li, S., Huang, J., Yin, G., Song, L., Jiang, Y. L., Zhao, S., & Lu, M. (2019) · Radiology · doi:10.1148/radiol.2019190651 · Cited by 137
Update on hypertrophic cardiomyopathy and a guide to the guidelines
Sen‐Chowdhry, S., Jacoby, D. L., Moon, J., & McKenna, W. J. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.140 · Cited by 133
Self-citationGuía ESC 2021 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2022) · Revista Española de Cardiología · doi:10.1016/j.recesp.2021.11.027 · Cited by 147
Lorenzini, M., Anastasiou, Z., O’Mahony, C., Guttmann, O. P., Gimeno, J. R., Monserrat, L., Anastasakis, A., Rapezzi, C., Biagini, E., García‐Pavía, P., et al. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.4534 · Cited by 127
Self-citationNorrish, G., Cantarutti, N., Pissaridou, E., Ridout, D. A., Limongelli, G., Elliot, P. M., & Kaski, J. P. (2017) · European Journal of Preventive Cardiology · doi:10.1177/2047487317702519 · Cited by 125
Self-citationVerdonschot, J. A. J., Merlo, M., Domínguez, F., Wang, P., Henkens, M. T. H. M., Adriaens, M. E., Hazebroek, M. R., Masè, M., Escobar-López, L., Paz, R. C., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa841 · Cited by 124
Long-Term Outcomes After Medical and Invasive Treatment in Patients With Hypertrophic Cardiomyopathy
Vriesendorp, P. A., Liebregts, M., Steggerda, R. C., Schinkel, A. F. L., Willems, R., ten Cate, F. J., Cleemput, J. V., ten Berg, J. M., & Michels, M. (2014) · JACC Heart Failure · doi:10.1016/j.jchf.2014.06.012 · Cited by 123
Global longitudinal strain is associated with heart failure outcomes in hypertrophic cardiomyopathy
Réant, P., Mirabel, M., Lloyd, G., Peyrou, J., López-Ayala, J. M., Dickie, S., Bulluck, H., Captur, G., Rosmini, S., Guttmann, O. P., et al. (2016) · Heart · doi:10.1136/heartjnl-2015-308576 · Cited by 123
Self-citationHypertrophic Cardiomyopathy–Related Sudden Cardiac Death in Young People in Ontario
Weissler‐Snir, A., Allan, K. S., Cunningham, K. S., Connelly, K. A., Lee, D. S., SPEARS, D. A., Rakowski, H., & Dorian, P. (2019) · Circulation · doi:10.1161/circulationaha.119.040271 · Cited by 123
Steinberg, J. S., Varma, N., Cygankiewicz, I., Aziz, P. F., Balsam, P., Baranchuk, A. M., Cantillon, D. J., Dilaveris, P., Dubner, S., El‐Sherif, N., et al. (2017) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.12447 · Cited by 123
Augusto, J. B., Davies, R. H., Bhuva, A., Knott, K. D., Seraphim, A., Alfarih, M., Lau, C. W. Z., Hughes, R. K., Lopes, L. R., Shiwani, H., et al. (2020) · The Lancet Digital Health · doi:10.1016/s2589-7500(20)30267-3 · Cited by 116
Muser, D., Nucifora, G., Muser, D., Nucifora, G., Pieroni, M., Castro, S. A., Casado-Arroyo, R., Maeda, S., Benhayon, D. A., Liuba, I., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.047640 · Cited by 114
Eberly, L. A., Day, S. M., Ashley, E. A., Jacoby, D. L., Jefferies, J. L., Colan, S. D., Rossano, J. W., Semsarian, C., Pereira, A. C., Olivotto, I., et al. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.4638 · Cited by 113
Rowin, E. J., Maron, B. J., Kiernan, M. S., Casey, S. A., Feldman, D. S., Hryniewicz, K. M., Chan, R. H. M., Harris, K. M., Udelson, J. E., DeNofrio, D. D., et al. (2014) · Circulation Heart Failure · doi:10.1161/circheartfailure.114.001435 · Cited by 111
Freitas, P., Ferreira, A. M., Arteaga-Fernández, E., Antunes, M. D. O., Mesquita, J., Abecasis, J., Marques, H., Saraiva, C., Matos, D. N., Rodrigues, R., et al. (2019) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-019-0561-4 · Cited by 102
Lopes, L. R., García-Hernández, S., Lorenzini, M., Futema, M., Сергеевна, Ч. О., Zateyshchikov, D. A., Isidoro‐García, M., Villacorta, E., Escobar-López, L., García‐Pavía, P., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab424 · Cited by 102
Self-citationSteeds, R. P., Garbi, M., Cardim, N. M., Kasprzak, J. D., Sade, L. E., Nihoyannopoulos, P., Popescu, B. A., Stefanidis, A. S., Cosyns, B., Monaghan, M. J., et al. (2016) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jew333 · Cited by 101
Hiemstra, Y. L., Debonnaire, P., Bootsma, M., van Zwet, E. W., Delgado, V., Schalij, M. J., Atsma, D. E., Bax, J. J., & Marsan, N. A. (2017) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.116.005706 · Cited by 101
Könemann, H., Dagres, N., Merino, J. L., Sticherling, C., Zeppenfeld, K., Tfelt‐Hansen, J., & Eckardt, L. (2023) · EP Europace · doi:10.1093/europace/euad091 · Cited by 105
Nielsen, J. C., Lin, Y., Figueiredo, M. J. D. O., Shamloo, A. S., Alfie, A., Bovéda, S., Dagres, N., Toro, D. D., Eckhardt, L. L., Ellenbogen, K. A., et al. (2020) · Journal of Arrhythmia · doi:10.1002/joa3.12338 · Cited by 106
Hindieh, W., Weissler‐Snir, A., Hammer, H., Adler, A., Rakowski, H., & Chan, R. H. M. (2017) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.117.006309 · Cited by 99
Nielsen, J. C., Lin, Y.-J., de Oliveira Figueiredo, M. J., Sepehri Shamloo, A., Alfie, A., Boveda, S., Dagres, N., Di Toro, D., Eckhardt, L. L., Ellenbogen, K., et al. (2020) · EP Europace · doi:10.1093/europace/euaa065 · Cited by 98
Metadata
- Authors
- O'Mahony, C., Jichi, F., Pavlou, M., Monserrat, L., Anastasakis, A., Rapezzi, C., Biagini, E., Gimeno, J. R., Limongelli, G., McKenna, W. J., Omar, R. Z., Elliott, P. M., & for the Hypertrophic Cardiomyopathy Outcomes Investigators
- Affiliations
- University College London (GB)
- National and Kapodistrian University of Athens (GR)
- University of Bologna (IT)
- Hospital Universitario Virgen de la Arrixaca (ES)
- University of Campania "Luigi Vanvitelli" (IT)
- University College Hospital at Westmoreland Street (GB)
- ORCID
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-10-14
- Volume
- 35
- Issue
- 30
- Pages
- 2010-2020
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2119361626
- Cited by
- 1,251
- References
- 50
- Citations by year
- 2026: 107 · 2025: 124 · 2024: 115 · 2023: 120 · 2022: 99 · 2021: 125 · 2020: 116 · 2019: 87 · 2018: 81 · 2017: 100 · 2016: 67 · 2015: 76 · 2014: 31 · 2013: 2
- FWCI
- 39.92
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Heart Journal (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Hispana (submittedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- RUNA. Repositorio Institucional del Sergas (Servicio Gallego de Salud (SERGAS)) (submittedVersion, other-oa)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, other-oa)
- Funders
- National Institute for Health and Care Research (NF-SI-0509-10230)
- Università di Bologna
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- hypertrophic cardiomyopathy, sudden cardiac death, risk prediction model, individualized risk estimation, implantable cardioverter-defibrillator, left ventricular wall thickness, left ventricular outflow tract gradient, family history of sudden cardiac death, non-sustained ventricular tachycardia, unexplained syncope, left atrial diameter, model validation
- MeSH terms
- Adult, Cardiomyopathy, Hypertrophic, Female, Humans, Male, Middle Aged, Prognosis, Retrospective Studies, Reproducibility of Results, Proportional Hazards Models, Death, Sudden, Cardiac, Sample Size, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
